Smart Eye Signs Breakthrough Deal for AIS Driver Monitoring System for Fleets with Linde
Smart Eye will deliver its complete hardware and software Driver Monitoring System (DMS) to Linde…
News
NCR Announces Filing of Form 10 Registration Statement for Planned Spin-Off of ATM Company
ATLANTA–(BUSINESS WIRE)–NCR Corporation (NYSE: NCR), a leading enterprise technology provider, today announced the filing of…
Oncotarget Publishes New Data by Lantern Pharma, an AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement of LP-284, a Novel Synthetically Lethal Drug Candidate for Non-Hodgkin’s Lymphomas
Non-Hodgkin’s lymphoma (NHL) is the seventh leading cause of cancer in the US, with 20-40%…
Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19
The Phase 3 study of Ovydso was initiated in China in February 2023 and enrolled…
Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
Promissory note extends cash runway into early Q3 2023 OLPRUVA™ expected to be available by…
Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
BOSTON, June 26, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes
CAMBRIDGE, Mass., June 26, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium
ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes…
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare…
ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth
FREMONT, CA, June 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage…
Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes
MINNEAPOLIS, June 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members
Twirla (levonorgestrel and ethinyl estradiol) transdermal system will be made available nationwide to members of…
BioVie Presents Data Highlighting Role of Insulin Resistance and Neuroinflammation in the Development of Mild to Moderate in Alzheimer’s Disease
Baseline Data from Phase 3 Trial of NE3107 Presented as Poster at the American Diabetes…
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
Ovid Therapeutics Added to Russell 3000® Index
NEW YORK, June 26, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Eyenovia Announces Addition to Russell 2000® and Russell 3000® Indexes
NEW YORK, June 26, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic…
Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes
NEW HOPE, Pa., June 26, 2023 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO,…
Portage Biotech Announces First Patient Dosed in Phase 1a Trial of PORT-6 in Select Solid Tumors
WESTPORT, Conn., June 26, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage…